brivaracetam
brivaracetam is listed in the FDA National Drug Code directory with 67 NDC codes, marketed under brand names including brivaracetam, Briviact, BRIVARACETAM. Available dosage forms: tablet, film coated, solution, injection, suspension, powder, injection.
Drug details
- Generic Name
- brivaracetam
- Brand Names
- brivaracetam, Briviact, BRIVARACETAM, Brivaracetam
- Application Number
- ANDA219952
- Sponsor
- ScieGen Pharmaceuticals, Inc.
- NDC Codes
- 67
- Dosage Forms
- TABLET, FILM COATED, SOLUTION, INJECTION, SUSPENSION, POWDER, INJECTION
- Routes
- ORAL, INTRAVENOUS
- Active Ingredients
- BRIVARACETAM
Indications and Usage
1 INDICATIONS AND USAGE BRIVIACT is indicated for the treatment of partial-onset seizures in patients 1 month of age and older. BRIVIACT is indicated for the treatment of partial-onset seizures in patients 1 month of age and older. ( 1 )